FI813971A7 - Uusia pyrimidinoneja, niiden valmistus ja niiden käyttö lääkeaineina. - Google Patents

Uusia pyrimidinoneja, niiden valmistus ja niiden käyttö lääkeaineina. Download PDF

Info

Publication number
FI813971A7
FI813971A7 FI813971A FI813971A FI813971A7 FI 813971 A7 FI813971 A7 FI 813971A7 FI 813971 A FI813971 A FI 813971A FI 813971 A FI813971 A FI 813971A FI 813971 A7 FI813971 A7 FI 813971A7
Authority
FI
Finland
Prior art keywords
pyrimidinones
pharmaceuticals
preparation
new
new pyrimidinones
Prior art date
Application number
FI813971A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI813971L (fi
Inventor
Rudolf Kadatz
Joachim Heider
Christian Lillie
Wolfgang Eberlein
Volkhard Austel
Original Assignee
Dr Karl Thomae Ges Mit
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19803046871 external-priority patent/DE3046871A1/de
Priority claimed from DE19813115447 external-priority patent/DE3115447A1/de
Application filed by Dr Karl Thomae Ges Mit filed Critical Dr Karl Thomae Ges Mit
Publication of FI813971L publication Critical patent/FI813971L/fi
Publication of FI813971A7 publication Critical patent/FI813971A7/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C07D239/91—Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/20—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 4
    • C07D265/22—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
FI813971A 1980-12-12 1981-12-10 Uusia pyrimidinoneja, niiden valmistus ja niiden käyttö lääkeaineina. FI813971A7 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19803046871 DE3046871A1 (de) 1980-12-12 1980-12-12 Neue chinazolinone, ihre herstellung und ihre verwendung als arzneimittel
DE19813115447 DE3115447A1 (de) 1981-04-16 1981-04-16 Neue pyrimidinone, ihre herstellung und ihre verwendung als arzneimittel

Publications (2)

Publication Number Publication Date
FI813971L FI813971L (fi) 1982-06-13
FI813971A7 true FI813971A7 (fi) 1982-06-13

Family

ID=25789685

Family Applications (1)

Application Number Title Priority Date Filing Date
FI813971A FI813971A7 (fi) 1980-12-12 1981-12-10 Uusia pyrimidinoneja, niiden valmistus ja niiden käyttö lääkeaineina.

Country Status (22)

Country Link
US (1) US4379788A (enExample)
EP (1) EP0054132B1 (enExample)
AR (1) AR227567A1 (enExample)
AU (1) AU543568B2 (enExample)
CA (1) CA1217767A (enExample)
CS (1) CS227024B2 (enExample)
DD (1) DD208151A5 (enExample)
DE (1) DE3166627D1 (enExample)
DK (1) DK525481A (enExample)
ES (2) ES8207156A1 (enExample)
FI (1) FI813971A7 (enExample)
GB (1) GB2090249B (enExample)
GR (1) GR76952B (enExample)
HU (1) HU187384B (enExample)
IL (1) IL64504A (enExample)
MY (1) MY8700562A (enExample)
NO (1) NO814239L (enExample)
NZ (1) NZ199254A (enExample)
PH (1) PH18930A (enExample)
PL (1) PL135330B1 (enExample)
PT (1) PT74116B (enExample)
SU (1) SU1056900A3 (enExample)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4460589A (en) * 1980-10-03 1984-07-17 The Upjohn Company Process for treating hypertension
US4379778A (en) * 1980-10-10 1983-04-12 Air Products And Chemicals, Inc. Hydrogen peroxide synthesis
DE3428476A1 (de) * 1984-08-02 1986-02-13 Basf Ag, 6700 Ludwigshafen 4h-pyrido(2,3-d)(1,3)oxazin-4-on-derivate, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses
DE3631294A1 (de) * 1986-09-13 1988-03-24 Thomae Gmbh Dr K Neue synergistische kombination bestehend aus einem phosphodiesterase-hemmer und einem thromboxan-a(pfeil abwaerts)2(pfeil abwaerts)-antagonisten und deren verwendung bzw. herstellung
US5037980A (en) * 1988-04-18 1991-08-06 American Cyanamid Company Phenyl imidazo[1,2-a]pyrimidines
GB8928346D0 (en) * 1989-12-15 1990-02-21 Smith Kline French Lab Chemical compounds
GB9126260D0 (en) * 1991-12-11 1992-02-12 Pfizer Ltd Therapeutic agents
GB9404485D0 (en) * 1994-03-09 1994-04-20 Cancer Res Campaign Tech Benzamide analogues
WO1999024433A1 (de) 1997-11-12 1999-05-20 Bayer Aktiengesellschaft 2-phenyl-substituierte imidazotriazinone als phosphodiesterase inhibitoren
RU2207337C2 (ru) * 1998-11-18 2003-06-27 Изаксон Елена Александровна 6-(3-ацетилфенил)аминоурацил
US20040102324A1 (en) 2002-02-28 2004-05-27 Annis Gary David Heterocyclic diamide invertebrate pest control agents
US6642244B2 (en) 2001-03-16 2003-11-04 Bristol-Myers Squibb Co. Pyrazolopyridopyrimidine inhibitors of cGMP phosphodiesterase
AU2002257195A1 (en) * 2001-04-23 2002-11-05 University Of Virginia Patent Foundation Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic agents
MXPA03010119A (es) * 2001-05-09 2005-03-07 Bayer Healthcare Ag Nuevo uso de imidazotriazinonas 2-fenilo sustituidas.
DE10232113A1 (de) 2002-07-16 2004-01-29 Bayer Ag Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel
EP1696927A4 (en) * 2003-12-19 2007-10-31 Merck & Co Inc INHIBITORS OF MITOTIC KINESINE
SE0401342D0 (sv) * 2004-05-25 2004-05-25 Astrazeneca Ab Therapeutic compounds
SE0401345D0 (sv) * 2004-05-25 2004-05-25 Astrazeneca Ab Therapeutic compounds: Pyridine as scaffold
EP1757594A4 (en) * 2004-05-31 2007-12-12 Banyu Pharma Co Ltd quinazoline derivative
DE102005001989A1 (de) * 2005-01-15 2006-07-20 Bayer Healthcare Ag Intravenöse Formulierungen von PDE-Inhibitoren
DE102005009241A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit kontrollierter Bioverfügbarkeit
DE102005009240A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften
AU2006299232A1 (en) * 2005-09-29 2007-04-12 Bayer Schering Pharma Aktiengesellschaft PDE inhibitors and combinations thereof for the treatment of urological disorders
MX2009003673A (es) * 2006-10-04 2009-04-22 Pfizer Prod Inc Derivados de piridido[4,3-d]pirimidin-4(3h)-ona como antagonistas de los receptores de calcio.
US20100184769A1 (en) * 2007-06-13 2010-07-22 Bayer Schering Pharma Aktiengesellschaft Pde inhibitors for the treatment of hearing impairment
CN101531638B (zh) * 2008-03-13 2011-12-28 中国科学院广州生物医药与健康研究院 用作雌激素相关受体调节剂的化合物及其应用
EP2273882A4 (en) * 2008-05-13 2011-07-13 Poniard Pharmaceuticals Inc BIOACTIVE COMPOUNDS FOR THE TREATMENT OF CANCER AND NEURODEEGENERATIVE DISEASES
CN101628913B (zh) 2008-07-18 2013-01-23 中国科学院广州生物医药与健康研究院 用作雌激素相关受体调节剂的化合物及其应用
BR112015006524A8 (pt) * 2012-09-26 2019-08-20 Merck Patent Gmbh derivados de quinazolinona como inibidores de parp, seu processo de preparação, seu uso, medicamentos e conjunto (kit)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3265697A (en) * 1964-09-04 1966-08-09 Shulton Inc 2-p-dialkylaminoalkoxyphenyl-2, 3-dihydro-4 (1h)-quinazolinones and their derivatives
DE1939109A1 (de) * 1968-08-31 1970-03-05 Troponwerke Dinklage & Co 2-Methyl-3-[2-(2-diaethylaminoaethoxy)-phenyl]-chinazolinon-(4) und Verfahren zu seiner Herstellung
US3862191A (en) * 1972-09-27 1975-01-21 Pfizer Pyrido{8 2,3-d{9 pyrimidin-4(3H)-one

Also Published As

Publication number Publication date
HU187384B (en) 1985-12-28
ES507761A0 (es) 1982-09-01
EP0054132B1 (de) 1984-10-10
DK525481A (da) 1982-06-13
ES8207156A1 (es) 1982-09-01
SU1056900A3 (ru) 1983-11-23
PL135330B1 (en) 1985-10-31
GB2090249B (en) 1984-08-22
DE3166627D1 (en) 1984-11-15
US4379788A (en) 1983-04-12
PT74116B (de) 1983-12-19
FI813971L (fi) 1982-06-13
ES511835A0 (es) 1983-02-16
GB2090249A (en) 1982-07-07
NO814239L (no) 1982-06-14
PT74116A (de) 1982-01-01
PL234175A1 (enExample) 1982-08-16
IL64504A (en) 1985-02-28
CS227024B2 (en) 1984-04-16
PH18930A (en) 1985-11-11
MY8700562A (en) 1987-12-31
DD208151A5 (de) 1984-03-28
NZ199254A (en) 1985-02-28
GR76952B (enExample) 1984-09-04
AU7847381A (en) 1982-06-17
IL64504A0 (en) 1982-03-31
EP0054132A1 (de) 1982-06-23
AU543568B2 (en) 1985-04-26
CA1217767A (en) 1987-02-10
ES8304096A1 (es) 1983-02-16
AR227567A1 (es) 1982-11-15

Similar Documents

Publication Publication Date Title
FI813971A7 (fi) Uusia pyrimidinoneja, niiden valmistus ja niiden käyttö lääkeaineina.
FI853626A7 (fi) Isoksatsolikarboksyylihappojohdannaiset, niiden valmistus ja käyttö.
FI831234A7 (fi) Uudet välituotteet, niiden valmistusmenetelmä ja niiden käyttö.
FI831457A7 (fi) 1-sulfo-2-atsetidinon-johdannaiset, niiden valmistus ja käyttö.
TR21476A (tr) Herbisidler olarak kullanilmaya elverisli n-fenilpirazol tuerevleri
FI830984A7 (fi) Uusi DNA ja sen käyttö.
FI845117A7 (fi) Uudet 2-fenyyli-imidatsolit, niiden valmistaminen ja näitä yhdisteitä sisältävät lääkeaineet.
FI830163A7 (fi) Fenyylietyleeni-johdannaisia, niiden valmistus ja käyttö lääkeaineina.
FI813934A7 (fi) Uusia fenyylialkyyliamiineja, niiden valmistus ja niiden käyttö lääkeaineina.
FI800770A7 (fi) Uudet indolijohdokset, niiden valmistaminen ja niiden käyttö lääkeaineina.
FI832575A7 (fi) Uusia 6,16- dimetyylikortikoideja, niiden valmistus ja käyttö.
FI803356A7 (fi) Uudet atsepinoindolit, niiden valmistus ja niitä sisältävät farmaseuttiset yhdisteet.
FI833075A7 (fi) 2-nitro-1,1-eteenidiamiineja, menetelmiä niiden valmistamiseksi sekä niiden käyttö lääkeaineina.
FI811532A7 (fi) Dioksidiyhdisteet, menetelmät niiden valmistamiseksi ja niiden käyttö.
FI823022A7 (fi) Amino-organoaminosilaanit, niiden valmistusmenetelmä ja niiden käyttö.
FI852657A7 (fi) Heterosyklisiä farmaseuttisia yhdisteitä, valmistus ja käyttö.
FI821824A7 (fi) Uusia karbasykliinejä, menetelmä niiden valmistamiseksi ja niiden käyttö lääkkeinä.
FI813289A7 (fi) Fosfonohydroksiasetonitriili, menetelmä sen valmistamiseksi ja sen käyttö välituotteena lääkeaineiden valmistuvalmistuksessa.
FI852647A7 (fi) 3-aminokarbonyylimetoksi-5 -fenyylipyratsoliyhdisteet ja niiden valmistusmenetelmä sekä näitä yhdisteitä sisältävät lääkeaineet.
FI822616A0 (fi) Markerat, immunologiskt aktivt medel
NL7902863A (nl) 7alpha-methoxycefalosporine verbindingen, hun gebruik en bereiding.
NL8004366A (nl) 25-halocholest-5-een-3beta,22-diolen en hun bereiding.
FI800350A7 (fi) Dehydropeptidejä, menetelmiä niiden valmistamiseksi sekä niiden käyttö lääkeaineina.
FI853621A7 (fi) Vinyylitetrasolyylifenyyli-johdannaisia, niiden valmistus ja käyttö.
FI792416A7 (fi) 1-bentsoyyli-3-pyridinyyli-karbamideja, niiden käyttö, valmistus ja seoksia.

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: DR. KARL THOMAE GESELLSCHAFT MIT